Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US-2015273058-A1 · Oct 1, 2015 · US
Method for alleviating fatigue
US11458178B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11458178-B2 |
| Application number | US-201816765070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 26, 2018 |
| Priority date | Nov 24, 2017 |
| Publication date | Oct 4, 2022 |
| Grant date | Oct 4, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a novel IL-1β and/or IL-6 expression inhibitor and use thereof. The IL-1β and/or IL-6 expression inhibitor in accordance with an aspect of the present invention contains a component derived from alcoholic fermentation lees.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for alleviating fatigue caused by brain inflammation, said method comprising the step of: administering, to a human or a non-human animal, an anti-fatigue composition comprising a component derived from alcoholic fermentation lees, wherein the component derived from alcoholic fermentation lees is a water extract of the alcoholic fermentation lees or a re-fermented product obtained by fermenting the alcoholic fermentation lees at least once by lactic acid fermentation and/or alcoholic fermentation. 2. A method for alleviating fatigue caused by brain inflammation, said method comprising the step of: administering, to a human or a non-human animal, a food or beverage composition comprising a component derived from alcoholic fermentation lees, wherein the component derived from alcoholic fermentation lees is a water extract of the alcoholic fermentation lees or a re-fermented product obtained by fermenting the alcoholic fermentation lees at least once by lactic acid fermentation and/or alcoholic fermentation. 3. The method according to claim 1 , wherein the brain inflammation is caused by expression of IL-1β and/or IL-6. 4. The method according to claim 3 , wherein the component derived from alcoholic fermentation lees inhibits expression of IL-1β and/or IL-6. 5. The method according to claim 1 , wherein the alcoholic fermentation lees are sake lees. 6. The method according to claim 3 , wherein the alcoholic fermentation lees are sake lees. 7. The method according to claim 4 , wherein the alcoholic fermentation lees are sake lees. 8. The method according to claim 2 , wherein the brain inflammation is caused by expression of IL-1β and/or IL-6. 9. The method according to claim 8 , wherein the component derived from alcoholic fermentation lees inhibits expression of IL-1β and/or IL-6. 10. The method according to claim 2 , wherein the alcoholic fermentation lees are sake lees. 11. The method according to claim 8 , wherein the alcoholic fermentation lees are sake lees. 12. The method according to claim 9 , wherein the alcoholic fermentation lees are sake lees.
Assignees
Inventors
Classifications
Adding ingredients (adding preservatives A23B70/10) · CPC title
Ascomycota · CPC title
- A61P25/00Primary
Drugs for disorders of the nervous system · CPC title
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11458178B2 cover?
- The present invention provides a novel IL-1β and/or IL-6 expression inhibitor and use thereof. The IL-1β and/or IL-6 expression inhibitor in accordance with an aspect of the present invention contains a component derived from alcoholic fermentation lees.
- Who is the assignee on this patent?
- Riken, Ozeki Kk
- What technology area does this patent fall under?
- Primary CPC classification A61P25/00. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).